KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.349 24 days ( 20.95 % )
Last Price $0.340 -1.90 %
High/ Low $0.330 - $0.347 10.12%
Chg 7 Days -2.66 % $0.349 $0.340
Chg 30 Days -20.02 % $0.425 $0.340
Chg 12 mos -64.87 % $0.97 $0.340
Trend - 3 mos -22.56 % Width: 46.75 %
Trend - 12 mos -64.75 % Width: 784.89 %
Pred. range - 3 mos $0.228 - $0.334 -33.06 % - -1.77 %
Pred. range - 12 mos $0.0144 - $0.127 -95.77 % - -62.58 %
Short MA avg 3 mos Buy Apr 18, 2024 - 7 days
Long MA avg 3 mos Sell Mar 25, 2024 - 24 days
Short/Long MA avg 3 mos Buy Mar 28, 2024 - 21 days
Short MA avg 12 mos Sell Apr 01, 2024 - 20 days
Long MA avg 12 mos Sell Mar 28, 2024 - 21 days
Short/Long MA avg 12 mos Sell Mar 18, 2024 - 29 days
Pivot Short Buy Apr 16, 2024 - 9 days
Bollinger Buy Apr 15, 2024 - 10 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT